Ligand ID: 5SF

Drugbank ID:
Erdafitinib
(DB12147)

Indication:
Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.

LIST OF BINDING INTERFACES for query 'DB12147'
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details
5EW8_A_5SFA803	5ew8	5SF	Erdafitinib (DB12147)	Homo sapiens	FIBROBLAST GROWTH FACTOR RECEPTOR 1	PK_Tyr_Ser-Thr	25	LEU A 484 GLY A 485 VAL A 492 ALA A 512 LYS A 514 LEU A 528 GLU A 531 MET A 535 ILE A 545 VAL A 559 VAL A 561 GLU A 562 TYR A 563 ALA A 564 SER A 565 LYS A 566 GLY A 567 GLU A 571 ARG A 627 ASN A 628 LEU A 630 ILE A 639 ALA A 640 ASP A 641 PHE A 642	5SF A 803		Details
DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details

[["5EW8_A_5SFA803","5ew8","5SF","Erdafitinib (DB12147)","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1","PK_Tyr_Ser-Thr",25,"LEU A 484;GLY A 485;VAL A 492;ALA A 512;LYS A 514;LEU A 528;GLU A 531;MET A 535;ILE A 545;VAL A 559;VAL A 561;GLU A 562;TYR A 563;ALA A 564;SER A 565;LYS A 566;GLY A 567;GLU A 571;ARG A 627;ASN A 628;LEU A 630;ILE A 639;ALA A 640;ASP A 641;PHE A 642","5SF A 803\r"]]